Directives anticipées : quels enjeux éthiques et quelles recommandations pratiques ?

Haas, S.; Guédon, E.; Joly, Clémence; Déchelotte, P.

doi:10.1016/s1765-4629(07)79753-2

Cited by 8 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This raises the question of the validity of ADs and the variation in choices over time. In 2007, Haas et al [8] con rmed that the view of patients can vary widely upon approaching end of life; it is not xed, and evolves, as Aubry had already suggested in 2006 [28]. Priorities change as death approaches.…”

Section: With Which Professional Do Patients Want To Discuss Ads?mentioning

confidence: 99%

“…Advance directives improve the psychological process in the face of death by reducing patient anxiety [5] and by providing emotional relief [6]. They help build relationships of trust [7,8] and therapeutic support [9]. Advance directives reduce the stress of patients' relatives [5], lifting the burdens of di cult decisions and offering the opportunity to refocus on…”

mentioning

confidence: 99%

See 1 more Smart Citation

Who Should Discuss Advance Directives With Patients With Cancer and When? A Systematic Literature Review

Boyer

Gimenez²,

Druel

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Among patients with cancer, discussion about the desired care is important, because progression of the disease, particularly signs of impaired consciousness, can lead to unwanted care in situations where no advance directives (ADs) have been provided. The aim of this study was to identify the most appropriate individual and time for addressing the subject of ADs with patients with cancer.Methods A systematic literature review was carried out between September 2014 and August 2015, using the following databases or sets of databases: PubMed, Web of Science, Cochrane Library, EM Premium, and the French database Public Health Data Bank. The methodological aspects of the articles were selected and evaluated with the help of PRISMA international guidelines.Results Of the 1170 articles identified, 7 were included (6 descriptive studies, 1 interventional study). A doctor was cited as the preferred individual for discussing the subject of advance directives with the patient. In 3 studies, this was listed as a general practitioner, whereas in the other 3 studies, it was an oncologist. The most opportune time was during the absence of a serious pathology (3 studies) and at the time the disease was diagnosed (2 studies).Conclusions Our results support the goals of Claeys-Leonetti, a 2016 French law concerned with the rights of patients receiving end-of-life care, and they suggest the implementation of a consultation for discussing and drafting ADs.

show abstract

Section: With Which Professional Do Patients Want To Discuss Ads?mentioning

confidence: 99%

mentioning

confidence: 99%

Who Should Discuss Advance Directives With Patients With Cancer and When? A Systematic Literature Review

Boyer

Gimenez²,

Druel

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…; souhaitez-vous un accompagnement spirituel et lequel ? » [12]. En ce qui concerne la rédaction des directives anticipées, 63,4 % des patients ressentent le besoin d'être informés et accompagnés par leur médecin [13].…”

Section: Interprétation Des Résultatsunclassified